tradingkey.logo
搜尋

Royalty Pharma PLC

RPRX
添加自選
58.440USD
-0.580-0.98%
收盤 07-31 16:00美東報價延遲15分鐘
25.93B總市值
30.42本益比TTM

RPRX 利潤表

您可以在這裡找到Royalty Pharma PLC的年度或季度收入報告,以深入了解Royalty Pharma PLC的營運、管理效率和表現。
單季報
單季報+年報
單季報
年報
YOY
隱藏空白列
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
FY2021Q1
FY2020Q4
FY2020Q3
FY2020Q2
FY2020Q1
FY2019Q4
FY2019Q3
FY2019Q2
FY2019Q1
營業總收入
10.97%630.58M
4.78%621.99M
7.90%609.29M
7.71%578.66M
0.05%568.25M
-0.41%593.64M
5.29%564.69M
-0.17%537.27M
-16.96%567.98M
5.36%596.07M
-6.48%536.31M
0.42%538.20M
21.69%683.97M
-1.73%565.75M
-2.10%573.46M
-3.43%535.96M
-1.92%562.05M
0.62%575.70M
8.80%585.77M
8.62%554.96M
14.40%573.03M
25.06%572.14M
15.97%538.40M
11.65%510.93M
15.18%500.88M
--457.49M
--464.28M
--457.61M
--434.88M
營業費用
-105.59%-1.91M
0.64%233.61M
206.90%182.13M
37.82%368.87M
-94.69%34.06M
1479.41%232.13M
-144.27%-170.38M
-7.51%267.64M
213.05%641.75M
-103.89%-16.83M
0.95%384.87M
82.95%289.36M
-40.12%205.00M
2.44%432.58M
34.85%381.25M
183.25%158.16M
-0.41%342.33M
229.82%422.28M
915.81%282.72M
-287.02%-189.99M
146.49%343.73M
114.64%128.03M
140.80%27.83M
-21.71%101.59M
3401.10%139.45M
---874.43M
---68.22M
--129.75M
--3.98M
研發費用
-21.21%39.79M
10000.00%50.50M
10000.00%50.50M
60000.00%300.50M
10000.00%50.50M
0.00%500.00K
-99.01%500.00K
0.00%500.00K
0.00%500.00K
-99.01%500.00K
98.04%50.50M
-17.49%500.00K
-99.50%500.00K
-51.36%50.50M
-71.82%25.50M
-80.59%606.00K
3705.38%100.50M
1234.63%103.82M
1675.90%90.50M
-45.95%3.12M
-65.43%2.64M
-50.98%7.78M
-77.57%5.10M
-73.08%5.78M
-66.77%7.64M
--15.87M
--22.72M
--21.46M
--22.99M
折舊攤銷及損耗
--1.17M
--1.20M
--1.28M
--1.38M
----
--0.00
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
0.00%5.80M
0.00%5.80M
0.00%5.73M
-13.12%5.73M
--5.80M
--5.80M
--5.73M
--6.60M
其他營業費用
-55.33%-197.49M
-85.91%23.11M
105.33%12.13M
-196.00%-203.94M
-121.79%-127.14M
314.39%164.04M
-182.13%-227.60M
-11.94%212.43M
391.23%583.60M
-124.77%-76.51M
-9.15%277.14M
128.19%241.23M
-35.65%118.80M
15.89%308.85M
121.32%305.06M
143.37%105.71M
-36.83%184.62M
314.21%266.50M
507.90%137.84M
-615.59%-243.76M
232.07%292.26M
107.00%64.34M
72.38%-33.79M
-34.53%47.28M
275.91%88.01M
---919.16M
---122.34M
--72.21M
---50.03M
營業利潤
18.40%632.48M
7.43%388.38M
-41.89%427.16M
-22.19%209.80M
824.08%534.18M
-41.02%361.51M
385.38%735.07M
8.35%269.63M
-115.40%-73.77M
360.23%612.90M
-21.21%151.44M
-34.13%248.84M
117.99%478.97M
-13.20%133.17M
-36.58%192.21M
-49.29%377.79M
-4.18%219.72M
-65.46%153.42M
-40.64%303.05M
81.99%744.95M
-36.56%229.30M
-66.66%444.11M
-4.12%510.57M
24.85%409.35M
-16.12%361.43M
--1.33B
--532.50M
--327.86M
--430.90M
淨非營業利息收入(費用)
利息收入
-44.83%6.23M
-21.76%7.07M
-60.57%6.90M
-37.77%8.33M
52.22%11.29M
39.03%9.04M
-25.29%17.51M
-47.84%13.38M
-55.59%7.42M
-85.18%6.50M
66.99%23.44M
134.94%25.65M
75.28%16.70M
312.19%43.85M
14.46%14.03M
-22.21%10.92M
-42.59%9.53M
-49.84%10.64M
672.59%12.26M
415.31%14.04M
480.76%16.60M
553.22%21.21M
-65.36%1.59M
-39.11%2.72M
-71.50%2.86M
--3.25M
--4.58M
--4.47M
--10.03M
利息費用
43.61%93.72M
43.20%94.17M
19.63%79.56M
40.10%68.67M
47.54%65.26M
39.16%65.76M
44.47%66.51M
4.40%49.01M
-5.79%44.23M
0.64%47.26M
-2.01%46.03M
-0.04%46.95M
-0.24%46.95M
-0.04%46.95M
5.98%46.98M
25.49%46.97M
25.79%47.06M
24.13%46.97M
40.97%44.33M
9.47%37.43M
-30.18%37.41M
-40.26%37.84M
-54.29%31.44M
-50.57%34.19M
-20.34%53.58M
--63.34M
--68.80M
--69.17M
--67.27M
出售證券收益
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--0.00
----
----
----
----
----
----
----
股權收益
237.70%21.76M
-87.35%4.00M
53.24%15.95M
58.13%2.69M
145.54%6.44M
11709.70%31.65M
299.29%10.41M
321.17%1.70M
-140.89%-14.15M
103.91%268.00K
-60.63%-5.22M
-204.48%-770.00K
8616.88%34.61M
81.97%-6.86M
-218.26%-3.25M
-95.84%737.00K
120.70%397.00K
-462.18%-38.02M
-80.00%2.75M
-39.57%17.70M
78.86%-1.92M
197.19%10.50M
270.89%13.74M
459.68%29.29M
-64.12%-9.07M
---10.80M
---8.04M
---8.14M
---5.53M
特殊收入(費用)
-91.97%-96.29M
58696.00%58.80M
-32.45%75.34M
-26.73%-59.97M
-140.40%-50.16M
-99.94%100.00K
69172.67%111.53M
-138.33%-47.32M
334.52%124.15M
122.33%163.49M
-99.79%161.00K
-17.77%123.47M
154.17%28.57M
-3459.14%-732.08M
247.02%75.20M
122.11%150.15M
-10.74%-52.74M
71.79%-20.57M
-139.95%-51.15M
-65.25%67.60M
74.48%-47.63M
-139.34%-72.92M
726.23%128.04M
355.26%194.54M
-768.76%-186.61M
--185.37M
---20.45M
---76.21M
--27.90M
其他非經營性收入(費用)
28.12%-2.20M
-273.23%-8.17M
4.78%-1.57M
-125.72%-1.54M
16.91%-3.06M
88.04%-2.19M
3.10%-1.65M
449.95%6.00M
-31.00%-3.69M
-1471.50%-18.31M
84.19%-1.71M
205.41%1.09M
-60.10%-2.81M
75.83%-1.17M
-1261.66%-10.80M
-867.29%-1.03M
-4186.05%-1.76M
-405.26%-4.82M
-144.98%-793.00K
-141.00%-107.00K
100.73%43.00K
1027.86%1.58M
659.91%1.76M
805.41%261.00K
-10312.07%-5.92M
--140.00K
--232.00K
---37.00K
--58.00K
稅前利潤
8.03%468.26M
6.45%355.91M
-44.91%444.21M
-53.37%90.64M
10243.53%433.43M
-53.41%334.35M
560.53%806.36M
-44.67%194.38M
-100.84%-4.27M
217.63%717.59M
-44.61%122.08M
-28.53%351.34M
297.47%509.09M
-1236.61%-610.03M
-0.62%220.41M
-39.06%491.60M
-19.43%128.08M
-85.36%53.67M
-64.47%221.80M
34.02%806.75M
45.72%158.98M
-74.65%366.63M
41.87%624.25M
236.73%601.98M
-72.46%109.10M
--1.45B
--440.03M
--178.77M
--396.09M
所得稅
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
除稅後利潤
8.03%468.26M
6.45%355.91M
-44.91%444.21M
-53.37%90.64M
10243.53%433.43M
-53.41%334.35M
560.53%806.36M
-44.67%194.38M
-100.84%-4.27M
217.63%717.59M
-44.61%122.08M
-28.53%351.34M
297.47%509.09M
-1236.61%-610.03M
-0.62%220.41M
-39.06%491.60M
-19.43%128.08M
-85.36%53.67M
-64.47%221.80M
34.02%806.75M
45.72%158.98M
-74.65%366.63M
41.87%624.25M
236.73%601.98M
-72.46%109.10M
--1.45B
--440.03M
--178.77M
--396.09M
持續經營利潤
8.03%468.26M
6.45%355.91M
-44.91%444.21M
-53.37%90.64M
10243.53%433.43M
-53.41%334.35M
560.53%806.36M
-44.67%194.38M
-100.84%-4.27M
217.63%717.59M
-44.61%122.08M
-28.53%351.34M
297.47%509.09M
-1236.61%-610.03M
-0.62%220.41M
-39.06%491.60M
-19.43%128.08M
-85.36%53.67M
-64.47%221.80M
34.02%806.75M
45.72%158.98M
-74.65%366.63M
41.87%624.25M
236.73%601.98M
-72.46%109.10M
--1.45B
--440.03M
--178.77M
--396.09M
歸屬少數股東的淨利潤
-11.03%173.57M
12.34%141.71M
-40.54%155.99M
-34.55%60.46M
2255.39%195.08M
-43.50%126.14M
425.13%262.37M
-25.33%92.37M
-105.38%-9.05M
245.02%223.25M
-35.75%49.96M
-33.88%123.71M
120.56%168.33M
-436.37%-153.95M
-35.13%77.76M
-48.88%187.09M
-15.07%76.32M
-76.59%45.77M
-64.07%119.87M
128.88%365.98M
137.37%89.86M
648.26%195.53M
974.64%333.62M
490.98%159.90M
32.13%37.86M
--26.13M
--31.05M
--27.06M
--28.65M
歸属于母公司的淨利潤
23.64%294.69M
2.88%214.21M
-47.02%288.22M
-70.42%30.18M
4888.47%238.35M
-57.88%208.21M
654.34%543.99M
-55.19%102.00M
-98.60%4.78M
208.39%494.34M
-49.45%72.11M
-25.25%227.63M
558.32%340.75M
-5870.29%-456.08M
39.95%142.65M
-30.92%304.50M
-25.11%51.76M
-95.38%7.90M
-64.93%101.93M
1216.85%440.78M
-2.98%69.12M
-87.95%171.09M
-28.94%290.63M
-77.94%33.47M
-80.61%71.24M
--1.42B
--408.98M
--151.71M
--367.44M
歸屬普通股東的淨利潤
23.64%294.69M
2.88%214.21M
-47.02%288.22M
-70.42%30.18M
4888.47%238.35M
-57.88%208.21M
654.34%543.99M
-55.19%102.00M
-98.60%4.78M
208.39%494.34M
-49.45%72.11M
-25.25%227.63M
558.32%340.75M
-5870.29%-456.08M
39.95%142.65M
-30.92%304.50M
-25.11%51.76M
-95.38%7.90M
-64.93%101.93M
1216.85%440.78M
-2.98%69.12M
-87.95%171.09M
-28.94%290.63M
-77.94%33.47M
-80.61%71.24M
--1.42B
--408.98M
--151.71M
--367.44M
基本每股收益
23.27%0.67
6.99%0.50
-45.09%0.67
-68.50%0.07
5039.15%0.55
-57.84%0.47
655.72%1.22
-55.25%0.23
-98.61%0.01
207.49%1.11
-50.48%0.16
-27.58%0.51
541.09%0.76
-5729.59%-1.03
36.43%0.32
-35.19%0.70
-32.74%0.12
-95.73%0.02
-69.70%0.24
1038.74%1.08
48.22%0.18
-82.00%0.43
14.35%0.79
-62.89%0.09
-80.61%0.12
--2.39
--0.69
--0.25
--0.62
稀釋每股收益
23.63%0.67
6.80%0.50
-45.17%0.67
-68.63%0.07
5056.76%0.55
-57.83%0.47
658.65%1.21
-55.20%0.23
-98.62%0.01
207.39%1.11
-50.70%0.16
-27.70%0.50
540.66%0.76
-5729.59%-1.03
36.33%0.32
-35.19%0.70
-32.74%0.12
-95.73%0.02
-69.70%0.24
1038.65%1.08
48.21%0.18
-82.01%0.43
14.35%0.79
-62.89%0.09
-80.61%0.12
--2.39
--0.69
--0.25
--0.62
每股派息
--0.00
106.82%0.46
-47.62%0.22
4.76%0.22
-100.00%0.00
10.00%0.22
110.00%0.42
5.00%0.21
--0.21
-48.72%0.20
5.26%0.20
5.26%0.20
--0.00
8.33%0.39
11.76%0.19
11.76%0.19
--0.00
12.50%0.36
13.33%0.17
--0.17
--0.00
--0.32
--0.15
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
貨幣單位
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
審計意見
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----

常見問題

如何在 TradingKey 上查看 Royalty Pharma PLC 的利潤表?

先看總營收,再依序查看營業成本、毛利、營業費用、營業利益、稅前淨利、淨利和每股盈餘(EPS)。營收反映公司的業務規模,而各項獲利和利潤率則體現公司能否有效地將營收轉化為獲利。

季度利潤表和年度利潤表有什麼區別?

季度利潤表反映公司在一個為期三個月的財務季度內的經營表現,年度損益表則彙總整個財年的業績。季度數據適合用於觀察近期發展勢頭和季節性變化,年度數據則更適合評估長期成長、獲利能力和業務週期。

利潤表頁面中的同比是什麼意思?

同比(即年增率,YoY)是指將某項財務指標與上年同期進行比較,例如將本季度營收與去年同一季度的營收進行對比。與去年同期比較的數據有助於投資者觀察成長趨勢,同時減少正常季節性變化對分析的影響。

分析 RPRX 股票時,哪些利潤表指標最重要?

重要的指標包括營收成長、毛利、毛利率、營業利益、營業利益率、淨利、每股盈餘、研發費用、銷售及管理費用以及所得稅費用。投資者通常會綜合分析這些指標,以判斷公司是否正在成長、有效控制成本並提升獲利能力。

Royalty Pharma PLC 財年末的營收是多少?

Royalty Pharma PLC 2025 財年營收為 2.38B,高於上一財年的 2.26B。

Royalty Pharma PLC 最近一個季度的營收是多少?

Royalty Pharma PLC 最近一個季度的營收為 630.58M,同比增長 10.97%。

Royalty Pharma PLC 全年的淨利潤是多少?

Royalty Pharma PLC 2025 財年淨利潤為 770.95M。

Royalty Pharma PLC 上一季度的淨利潤是多少?

Royalty Pharma PLC 最近一個季度的淨利潤為 294.69M。

Royalty Pharma PLC 年度營業利潤是多少?

Royalty Pharma PLC 2025 財年的營業利潤為 1.56B。

每股收益與利潤表有什麼關係?

每股收益(EPS)通常以淨利潤除以流通在外的股份數量計算,用於衡量公司平均每股創造的利潤。分析 EPS 時,還應結合股本變化、利潤率、現金流和估值指標進行綜合判斷。
tradingkey.logo
風險提示:我們的網站和行動應用程式僅提供關於某些投資產品的一般資訊。Finsights 不提供財務建議或對任何投資產品的推薦,且提供此類資訊不應被解釋為 Finsights 提供財務建議或推薦。
投資產品存在重大投資風險,包括可能損失投資的本金,且可能並不適合所有人。投資產品的過去表現並不代表其未來表現。
Finsights 可能允許第三方廣告商或關聯公司在我們的網站或行動應用程式的任何部分放置或投放廣告,並可能根據您與廣告的互動情況獲得報酬。
© 版權所有: FINSIGHTS MEDIA PTE. LTD. 版權所有